| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |